Michael Zimmerman, MD
Cardiovascular Disease · Charlotte, NCNPI 1184086951
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Boston Scientific at 31.3% of the total. Reporting peaked in 2023 at $3,164 and has fallen 75.9% since, to $761 in 2025.
Across 81 payments — averaging $113.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$3K
- Abbott$3K
- Biosense Webster, Inc.$467
- Philips North America LLC$241
- Zimmer Biomet$60
- plus $104 from 5 others
What the payments were for
- Travel & lodging$4,72251%
- Food & beverage$4,10945%
- Education$3784%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $2,882 |
| Medtronic | 33 | $2,792 |
| Abbott | 19 | $2,664 |
| Biosense Webster, Inc. | 8 | $467 |
| Philips North America LLC | 2 | $241 |
| Zimmer Biomet | 1 | $60 |
| Atricure, Inc. | 1 | $26 |
| Elutia, Inc. | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$1,596
- EVERA MRI XT DR SURESCAN$1,100
- VersaCross Access Solution$282
- ENSITE$270
- Carto 3$266
- (9520) IGT Devices Undivided$174
- AURORA EV-ICD MRI SURESCAN$169
- WATCHMAN FLX$156
- JOT DX$154
- AFFERA MAPPING SYSTEM$151
- Micra$150
- AVEIR$139
- SmartAblateTM System RF Generator$104
How this compares
$9,209 in reported general payments places this provider in the 75th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 12 | $293 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Charlotte
- Michael RinaldiCharlotte$722K
- Markus SchererCharlotte$526K
- Sanjeev GulatiCharlotte$406K
- Richard BrowneCharlotte$379K
- Rohit MehtaCharlotte$189K
- Brian PowellCharlotte$160K
- Nicole Cyrille-SupervilleCharlotte$115K
- Noreen KellyCharlotte$84K
- Dermot PhelanCharlotte$76K
- Charles SimontonCharlotte$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.